Headquartered in Lakewood, Colorado, Terumo Blood and Cell Technologies is a global leader in blood component, therapeutic apheresis, and cellular therapy technologies, serving customers in more than 150 countries. We believe in the potential of blood and cells to do even more for patients than they do today. This belief unites our organization, inspires our innovation, and strengthens our collaboration with customers.
We are proud to offer an industry-leading therapeutic apheresis platform, multiple therapeutic protocols, and data, consulting, support; automated platforms and services to support cell therapy developers and researchers; plasma collection technology, services, and software; automated blood collection and processing innovations; and pathogen reduction technology.
Originally established in 1964 as COBE Laboratories, today, nearly 7,000 associates around the world are deeply committed to mission to Contribute to Society through Healthcare. One way we back these words is through our pledge to be a conscientious corporate citizen and conduct our business in a way that provides social, environmental, and economic benefit.
At Terumo Blood and Cell Technologies, discovery never stops. We share a passion for thinking in new and different ways and we are proud to support education and research through a variety of community involvement activities as well as by providing opportunities to advance treatment options for patients. We know the work we do matters and has the potential to fundamentally improve health care. We remain dedicated to ensuring the lifesaving gift of blood is available around the world and to meeting and exceeding the needs of our customers and the patients we ultimately serve.
For members
International Society For Apheresis
Postcode: 520-2192
Shiga University of Medical Science,
Seta Tsukinowa-cho, Otsu,
Shiga 520-2192, Japan